CCDS Development for Investigational Products
The complexity of global drug development continues to increase as pharmaceutical companies conduct multi-regional clinical trials, pursue simultaneous market authorizations, and navigate evolving Regulatory requirements across multiple jurisdictions. According to industry estimates, more than 50% of clinical development programs today involve multiple countries, requiring organizations to...
0 Commentaires 0 Parts 117 Vue 0 Aperçu
Commandité